See RESULTS
VEVYE works fast so you can leave dry eyes behind
See RESULTS
VEVYE works fast so you can leave dry eyes behind
Stop the wait. Expect more.
In clinical trials:
VEVYE started to repair the physical damage caused by dry eye disease in as little as 15 days.
VEVYE increased natural tear production by day 29.
Patients using VEVYE, on average, were nearly back to normal, healthy tear production levels by week 56.
Patient-reported improvement in dry eye symptoms at day 29
Within a month of starting treatment, patients using VEVYE,
on average, reported an improvement in:
-
The sensation, frequency, and awareness of dry eyes
-
Blurred and fluctuating vision
-
The ability to read, drive at night, and look at screens
VEVYE starts working fast, bringing you relief from symptoms such as burning, stinging, and itching within the first month.
Tough on dry eye disease.
Gentle on your eyes.
VEVYE has a unique formulation that reduces stinging and irritation for a dry eye treatment you can stick with.
In clinical trials of VEVYE:
99.8% of patients reported mild to no pain when applying VEVYE
In a 52-week study, only 1 patient stopped using VEVYE, due to mild burning and stinging
Side effects were rare and, in most cases, mild. The most common side effects were mild eye irritation (8%) and temporary decreases in clarity of vision (3%)
Stay Connected
Sign up to receive VEVYE updates.
*By participating in the program, patients acknowledge that they currently meet the eligibility criteria. This program is only available for eligible commercially insured patients who are dispensed VEVYE by PhilRx or another participating pharmacy. This offer is not valid for patients with government insurance, including, but not limited to, Medicaid or Medicare. A patient’s out-of-pocket cost may be greater based on patient’s plan benefit design. Additional terms and conditions apply. All patients, including uninsured, commercially insured, and government insured, may be eligible for manufacturer cash discount pricing subject to program terms and conditions for opt-out.
INDICATION AND USAGE: VEVYE (cyclosporine ophthalmic solution) 0.1% is a prescription drop used to treat the signs and symptoms of dry eye disease.
IMPORTANT SAFETY INFORMATION
-
To avoid the potential for eye injury and/or contamination, do not touch the bottle tip to the eye or other surfaces.
-
VEVYE should not be administered while wearing contact lenses. Remove contacts prior to using VEVYE. After applying VEVYE to the eyes wait 15 minutes before reinserting contact lenses.
-
The most common side effects include eye irritation (8%) and temporary blurred vision (3%).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
For additional information about VEVYE, please see the Full Prescribing Information.
